These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8792962)

  • 21. Cisapride.
    Menezes O
    Aust Nurses J; 1991 Oct; 21(4):27. PubMed ID: 1750810
    [No Abstract]   [Full Text] [Related]  

  • 22. Cisapride improves gallbladder kinetics in patients affected with myotonic muscular dystrophy.
    Marchi S; Polloni A; Bellini M; Orsitto E; Costa F; Spataro M; Rossi B; Siciliano G; Masi MC; Tumino E
    Int J Clin Pharmacol Res; 1993; 13(1):53-8. PubMed ID: 8509236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cisapride on excessive regurgitation in infants.
    Van Eygen M; Van Ravensteyn H
    Clin Ther; 1989; 11(5):669-77. PubMed ID: 2805024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic interaction between fluoxetine and donepezil: a case of cholinergic toxidrome.
    Marshall K; Fritz K; Thom W; Xiong GL
    J Neuropsychiatry Clin Neurosci; 2012; 24(2):E50. PubMed ID: 22772705
    [No Abstract]   [Full Text] [Related]  

  • 25. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consultation-liaison psychiatry drug--drug interactions update.
    Armstrong SC; Cozza KL; Cole MA
    Psychosomatics; 2000; 41(4):375-6. PubMed ID: 10906369
    [No Abstract]   [Full Text] [Related]  

  • 27. Donepezil: suspected adverse reactions.
    CMAJ; 1998 Jul; 159(1):81, 85. PubMed ID: 9679497
    [No Abstract]   [Full Text] [Related]  

  • 28. [The neuroleptic malignant syndrome].
    Cuesta López MJ; Moreno Brea MP; Muñoz Málaga A
    Med Clin (Barc); 1994 Oct; 103(14):557-8. PubMed ID: 7799672
    [No Abstract]   [Full Text] [Related]  

  • 29. Mirtazapine and the granulocytes--so far so good.
    Meyboom RH; Edwards IR; Egberts AC
    N Z Med J; 1999 Mar; 112(1084):104. PubMed ID: 10210300
    [No Abstract]   [Full Text] [Related]  

  • 30. Nefazodone-induced carbamazepine toxicity.
    Ashton AK; Wolin RE
    Am J Psychiatry; 1996 May; 153(5):733. PubMed ID: 8615427
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.
    Desta Z; Soukhova NV; Flockhart DA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):382-92. PubMed ID: 11158730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR; Nemeroff CB
    Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cisapride efficacy in gastroesophageal reflux in children].
    Bottaro G; Rotolo N; Spina M; Azzaro F; Galletta C; Romano D; Castiglione N; Patanè R
    Pediatr Med Chir; 1993; 15(2):141-4. PubMed ID: 8321715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
    Grimm SW; Dyroff MC
    Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quercetin not only inhibits P-glycoprotein efflux activity but also inhibits CYP3A isozymes.
    Sarkar MA
    Cancer Chemother Pharmacol; 1995; 36(5):448-50. PubMed ID: 7634387
    [No Abstract]   [Full Text] [Related]  

  • 38. An interim overview of the safety and tolerability of paroxetine.
    Dunbar GC
    Acta Psychiatr Scand Suppl; 1989; 350():135-7. PubMed ID: 2530767
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxic hepatitis due to femoxetine.
    Aunsholt NA; Agnholt J
    Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):253-4. PubMed ID: 3716819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P-450 monooxygenases and interactions of psychotropic drugs.
    Shen WW; Lin KM
    Int J Psychiatry Med; 1991; 21(1):47-56. PubMed ID: 2066257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.